Brevetti EPO No.3727423 2024.05.22
Brevetti EPO
(10) Registration Number and Date
2024000277 2024.07.04
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000277 2018.12.21
(40) Publication Number and Date
SM /T/2024/000277 2024.07.04
(30) Priority Details
US 201762609489 P
2017.12.22
(51) IPC Classes
(72) Inventor
(IT) GOLDFINE, Allison : c/o Novartis Institutes for Biomedical Research,Inc. 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, US
(IT) YI, Byungdoo Alexander : c/o Novartis Institutes for Biomedical Research,Inc. 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, US
(74) Representative Name
(IT) FERRIERO, Paolo : Via del Serrone, 109, 47897 Fiorentino RSM, SM
(54) Title
(IT) TRATTAMENTO DI DISTURBI METABOLICI CON VARIANTI DI FGF21
(EN) TREATMENT OF METABOLIC DISORDERS WITH FGF21 VARIANTS
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2024.09.17
Event NameDateStatus
Filing2018.12.21Filed
Brevetto EPO concesso2024.07.04Published
Ricevuta pagamento annualita 72024.11.29Payed